Gene Query: FAM81A

Dataset Description Geneva Score
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 154.29
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 28.11
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 22.69
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 22.34
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 21.26
The landscape of alternative splicing in aggressive prostate cancers 19.07
RNA-seq of cancer cell lines treated with T-025 13.77
Genome-wide analysis of the Integrator complex 13.21
Genome-wide analysis of the Integrator complex (HTS) 13.21
The cohesin complex prevents Myc-induced replication stress 13.2
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 11.83
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 10.68
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 10.63
Gene expression analysis of the impact of TDP-43 knockout in human cells. 10.02
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 9.5
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 9.18
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 9.18
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 8.63
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 8.32
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 8.32
MeRIP-seq for heat shock in B-cell lymphoma cells 8.24
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 7.99
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 7.51
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 7.23
A549 cells and MSR-A549 cells 7.23
Oncogenic MYC induces a dependency on the spliceosome in human cancer 6.77
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 6.77
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 6.77
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 6.74
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 6.7
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 6.19
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 6.16
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 6.16
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 6.12
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 6.09
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 6.09
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 5.91
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 5.74
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 5.73
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 5.67
Global epigenomic reconfiguration during mammalian brain development 5.56
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 5.42
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 4.91
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 4.91
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 4.74
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 4.74
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 4.73
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 4.73
Transcriptional profiles of normal human mature B cells 4.6
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 4.52
Tracing Enhancer Networks using Epigenetic Traits (TENET) 4.3
The Glioma-Infiltrating T Cell Receptor Repertoire 4.08
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 3.97
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 3.97
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 3.97
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 3.82
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 3.82
Effect of PRDM11 depletion in U2932 cells 3.82
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 3.73
Gene expression changes associated with resistance to tagraxofusp (SL-401) 3.7
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 3.62
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 3.55
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 3.55
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 3.48
The pause-initiation limit restricts transcription activation in human cells 3.43
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 3.34
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 3.34
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 3.29
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 3.22
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 3.13
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 3.06
RNA-seq analysis of control and Myc-induced U2OS cells 3.05
Uridylation by TUT4 and TUT7 marks mRNA for degradation 3.04
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 3.01
Transcriptional profiling of LS1034 cells treated with tepoxalin 3.01
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 3.01
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 2.99
Genes significantly down or Up-regulated upon RNF219 knockdown 2.99
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 2.98
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 2.95
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 2.94
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 2.83
Widespread intronic polyadenylation diversifies immune cell transcriptomes 2.8
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 2.78
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 2.78
RNA-seq analyisis of PUM2 knockout cells 2.75
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 2.73
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 2.69
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 2.66
ARS2 is a general suppressor of pervasive transcription [RNAseq] 2.62
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 2.6
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 2.6
IDH3a KO RNA-seq 2.59
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 2.59
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 2.57
Sensing self and nonself circular RNAs 2.55
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 2.49
Accurate annotation of human protein-coding small open reading frames 2.38
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 2.27
G-quadruplex structures mark human regulatory chromatin 2.25
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 2.24
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 2.24
LIN28A modulates splicing and gene expression programs in breast cancer cells 2.2
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 2.2
Epigenetic reprogramming of melanoma cells by vitamin C treatment 2.2
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 2.19
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 2.19
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 2.19
ChIP-seq and RNA-seq from human lymphoma cell lines 2.19
RNA-seq data from human lymphoma cell lines 2.19
Genome-wide analysis of Dengue virus 2 infected cells 2.18
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 2.13
Nutritional control of protein translation 2.11
TGF-β promotes genomic instability after loss of RUNX3 2.05
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 2.05
RNAseq in Alzheimer's Disease patients 2.04
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 1.98
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 1.97
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 1.92
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 1.87
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 1.87
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 1.85
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 1.84
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 1.79
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 1.79
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 1.78
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 1.77
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 1.77
hnRNP C is a key regulator of protein synthesis in mitosis 1.77
Landscape and variation of RNA secondary structure across the human transcriptome 1.75
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 1.74
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 1.74
Transcriptomic profile of human embryonic renal corpuscles 1.73
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 1.72
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 1.72
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 1.68
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 1.65
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 1.62
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 1.62
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 1.59
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 1.56
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 1.56
RNA sequencing with KSHV infection and enrichment for circular RNAs 1.52
Gene expression changes upon drug withdrawal (Mel888 cell line) 1.52
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 1.5
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 1.49
mRNA recovered upon RNF219 IP. [RNA-IP] 1.49
Identification of HOXB13 target genes responsive to BET inhibitors 1.47
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 1.46
Primate transcript and protein expression levels evolve under compensatory selection pressures 1.45
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 1.45
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 1.45
Differentially expressed genes post knock down of lincDUSP26 1.44
RNA seq comparison between scrambled and shGRP78 cells 1.44
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 1.42
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 1.42
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 1.42
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells 1.42
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 1.42
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 1.39
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 1.39
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 1.39
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 1.37
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 1.34
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 1.33
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 1.33
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 1.33
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 1.33
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 1.31
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 1.27
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 1.27
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 1.27
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 1.27
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 1.26
Transcriptome analysis of SKI knock-out in HL60 cells 1.25
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 1.25
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 1.24
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 1.24
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 1.23
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 1.21
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 1.21
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 1.21
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 1.19
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 1.18
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 1.18
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 1.16
Transcription control by the ENL YEATS domain in acute leukemia 1.15
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 1.15
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 1.15
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 1.15
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 1.15
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 1.14
A novel target of EZH1/2 for treatment of mantle cell lymphoma 1.12
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 1.12
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 1.11
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 1.1
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 1.1
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 1.1
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 1.1
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 1.09
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 1.09
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 1.07
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 1.04
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 1.04
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 1.03
EP400 is required for Max and MCPyV mediated gene activation 1.02
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 1.02
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 1.02
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 1.02
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 1.01
Cleavage Factor Im as a key regulator of 3’ UTR length 1.0
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 0.98
RNA Sequencing of three pairs of gastric cancer 0.97
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 0.97
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 0.96
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 0.95
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 0.94
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 0.94
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 0.94
ADAR1-editing of cellular and measles virus-derived duplex RNA 0.94
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 0.94
Mitochondrial dsRNA triggers antiviral signalling in humans 0.94
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 0.93
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 0.92
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 0.92
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 0.91
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 0.91
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 0.89
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 0.89
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 0.89
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 0.89
Cell responses to dysregulated VZV-induced cell-cell fusion 0.88
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 0.88
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 0.88
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 0.88
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 0.87
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 0.87
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 0.86
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 0.86
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 0.86
A prostate cancer chromatin interaction map 0.85
MYCi975 regulates MYC target genes 0.85
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 0.85
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 0.84
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 0.84
m6A-dependent regulation of messenger RNA stability 0.84
Dynamic 3D chromosomal landscapes in acute leukemia 0.83
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 0.83
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 0.83
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 0.82
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 0.82
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 0.81
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 0.81
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 0.8
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 0.8
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 0.8
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 0.8
Genome-wide discovery of human splicing branchpoints [RNAse] 0.8
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 0.79
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 0.79
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 0.77
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 0.77
Regulation of highly expressed hCINAP on translatome 0.77
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 0.77
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 0.77
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 0.77
RNA-seq analysis of uveal melanoma cells treated with FR900359 0.75
The role of the Calcium-Sensing receptor in colorectal cancer 0.75
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 0.75
nELAVL HITS-CLIP in Alzheimer's Disease patients 0.75
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 0.75
Patient-derived xenograft platform for metastatic melanoma 0.74
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 0.74
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 0.74
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 0.73
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 0.73
Lysine benzoylation is a novel histone mark 0.73
Lysine benzoylation is a novel histone mark [RNA-seq] 0.73
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 0.73
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 0.72
Seletive inhibition of CDK9 in DLBCL cell lines 0.72
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 0.71
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 0.71
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 0.71
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 0.71
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 0.71
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 0.7
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 0.7
WRN knockout effects upon gene expression in SW48 and OVK18 0.7
Transcriptome analysis of human lung epithelial cells 0.7
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 0.7
RNA-seq of YB5 cells treated with Proscillaridin A 0.69
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 0.69
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 0.69
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 0.69
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 0.69
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 0.69
The regulartory role of ZCCHC24 in splicing machinery 0.68
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 0.67
RNA-seq analysis of BAP1-depleted uveal melanoma cells 0.67
mRNA-Seq profiling of human developing kidney 0.67
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 0.67
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 0.66
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 0.66
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 0.65
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 0.65
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 0.65
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 0.65
Gene expression changes due to PARP knockdown in human cells 0.64
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 0.64
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 0.64
Genome-wide discovery of human splicing branchpoints 0.63
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 0.63
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.62
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 0.62
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 0.62
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 0.62
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 0.61
Ro60-knockout cells 0.61
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 0.61
RNA sequencing of human mammary epithelial cells 0.61
Silencing SPIB in attached and floating state of H1703 lung cancer cells 0.6
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 0.6
An acquired vulnerability of drug resistant melanoma with therapeutic potential 0.6
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 0.6
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 0.6
EWSR1 influences alternative splicing through direct and indirect mechanisms 0.6
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 0.59
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 0.59
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 0.59
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 0.58
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 0.58
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 0.57
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 0.57
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 0.57
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 0.57
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 0.57
FBXW7 modulates stress response by post-translational modification of HSF1 0.57
MOF acetyl transferase regulates transcription and respiration in mitochondria 0.56
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 0.55
A549 cell transcriptome responses to infection with H7N9 influenza virus 0.55
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 0.55
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 0.55
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 0.53
circRNA-sequencing 0.53
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 0.52
The Genetic Landscape of Diamond-Blackfan Anemia 0.51
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 0.51
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 0.51
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.5
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.5
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 0.5
Effect of PBK knockdown on C4-2 cell transcriptome 0.5
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 0.5
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 0.49
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 0.49
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 0.49
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 0.48
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 0.47
BACH2 in human plasma cell fate decision 0.47
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 0.47
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 0.46
Transcriptome profiling of 5 human adenocarcinoma cell lines 0.46
Exploring ILF2 regulatory genes by next-generation sequencing 0.46
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 0.45
Repurposing of promoters and enhancers during mammalian evolution 0.45
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.45
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 0.45
Alteration of the microRNA network during the progression of Alzheimer’s disease 0.45
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 0.44
Molecular analysis of renal cell carcinoma with unclassfied histology 0.44
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 0.44
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 0.44
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 0.44
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 0.44
Identification of expressed and conserved human non-coding RNAs 0.43
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 0.43
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 0.43
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 0.43
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 0.42
Illumina Total RNA-seq in HeLa 0.42
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 0.42
TOP2B disturbed the quality of human oocytes with advanced maternal age 0.42
Gene expression profile in breast cancer cell lines using RNA sequencing 0.41
RNA-seq analysis and shRNA screen of breast cancer 0.4
RNA-seq analysis of breast cancer 0.4
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 0.39
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 0.38
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 0.38
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 0.38
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 0.38
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 0.37
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 0.37
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 0.37
SOX11 knockdown in B-ALL cell lines 0.35
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 0.35
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 0.35
Expression data from miR340 overexpressing human A549 cells 0.35
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 0.34
Cajal bodies are linked to genome conformation 0.34
Cajal bodies are linked to genome conformation [RNA-Seq] 0.34
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 0.32
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 0.31
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 0.31
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 0.3
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 0.29
RNA sequencing analysis of selumetinib-resistant CRC cells lines 0.28
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 0.28
The age and genomic integrity of neurons after cortical stroke in humans 0.28
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 0.28
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 0.28
Transcriptional dependencies in diffuse intrinsic pontine glioma 0.28
RNA-Seq of the corpus callosum from 12 individuals 0.26
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 0.26
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.26
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 0.25
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 0.25
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 0.25
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 0.25
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 0.25
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.25
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 0.25
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 0.23
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 0.23
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 0.23
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 0.22
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 0.21
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 0.21
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 0.2
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 0.2
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 0.19
Transcriptome-wide modulation of splicing by the exon junction complex 0.19
JAK dependent survival of ALK- ALCL 0.18
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.18
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 0.18
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 0.17
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 0.17
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 0.16
RNA-seq of primary patient AML samples 0.16
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 0.16
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 0.16
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.16
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 0.16
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 0.16
Myc activation coordinates gene transcription and protein translation responses 0.16
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 0.16
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.15
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 0.15
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 0.14
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 0.14
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 0.14
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 0.14
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 0.13
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 0.13
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 0.11
6mer seed toxicity in viral microRNAs 0.11
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 0.11
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 0.1
CD73 knockdown effect in pancreatic cancer cell lines 0.1
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 0.1
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.1
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.1
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.09
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 0.09
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 0.09
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 0.08
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.07
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 0.07
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.06
Enhancer activation during EGF response 0.06
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 0.06
N6-methyladenine DNA Modification in Glioblastoma 0.06
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.06
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.06
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 0.06
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 0.05
High-resolution comparative analysis of great ape genomes 0.05
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 0.05
Transcriptomic analysis of LSD1 0.04
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 0.04
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.04
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.04
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 0.04
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 0.04
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 0.04
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 0.04
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 0.04
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 0.04
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.03
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.03
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 0.03
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 0.03
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 0.03
Transcriptional changes in lymphoma cells induced by LSD1 depletion 0.03
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 0.03
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 0.02
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.01
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 0.01
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 0.0
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation